Drugs Made In America Acquisition Corp.
DMAA
$10.33
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.45M | 3.26M | 974.60K | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.31M | -3.89M | -1.46M | -- | -- |
| Change in Net Operating Assets | 323.00K | 146.40K | 110.20K | -- | -- |
| Cash from Operations | -537.20K | -481.10K | -374.40K | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -231.15M | -231.15M | -231.15M | -- | -- |
| Cash from Investing | -231.15M | -231.15M | -231.15M | -- | -- |
| Total Debt Issued | 1.39M | 1.39M | 1.39M | -- | -- |
| Total Debt Repaid | -1.93M | -1.93M | -1.93M | -- | -- |
| Issuance of Common Stock | 232.49M | 232.43M | 232.32M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -257.20K | -257.20K | -257.20K | -- | -- |
| Cash from Financing | 231.69M | 231.63M | 231.52M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -400.00 | -300.00 | -200.00 | -- | -- |